COGT vs CVX · $5.75B cap vs P/E 17, rev $118.66B
Cogent Biosciences Inc (COGT) versus Chevron Corp (CVX) — a side-by-side from cached financials, not a winner call.
Cogent Biosciences Inc (COGT) is a biotechnology company listed on NASDAQ.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Michael K. Wirth.
COGT does not have a complete income-statement cache yet.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
COGT currently screens at market cap $5.75B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Not investment advice. Open the COGT and CVX stock pages for the full models.
Not investment advice.